Kazakhstan, Kyrgyzstan, Uzbekistan to Manufacture Russian Horse Vaccine Under License

A Russian-developed vaccine against strangles, a contagious disease affecting horses, will soon be produced in Kazakhstan, Kyrgyzstan, and Uzbekistan under newly negotiated licensing agreements.

The announcement was made by Dr. Mikhail Neustroev, Chief Researcher and Head of the Veterinary Biotechnology Laboratory at the Yakut Scientific Research Institute of Agriculture, during the Eastern Economic Forum panel “Agroindustry of the Far East: A Look into the Future”, The Caspian Post informs via Kyrgyz media.

“Our vaccine is already being manufactured under license in Mongolia, and we’re currently finalizing similar agreements with bio-industrial producers in Central Asia,” Neustroev stated. “In July, the vaccine was granted a Eurasian patent, marking a major step toward broader regional distribution.”

He also noted that a business delegation to Uzbekistan is planned for late September, supported by the Export Support Center of the Republic of Sakha (Yakutia).

Strangles is an acute bacterial infection that primarily targets the lymph nodes of young horses and can cause serious complications. The vaccine was first developed by Yakut researchers in 2001, and after further refinement, it was re-registered in 2021 in its current, improved form.

The expansion of vaccine production across Central Asia is expected to strengthen regional biosecurity and support the growing equine industry in the Eurasian region.